ENOXABARA® Enoxaparin 80 mg | Libya
Advanced solution designed to reduce the risk of thrombosis and improve patient safety.
Enoxaparin 80 mg Injection | BAYADERCARE Libya
Therapeutic anticoagulation is critical in managing moderate to high-risk thrombotic conditions. LMWH therapies such as enoxaparin are widely used in Libyan hospitals due to their effectiveness and predictable response.
|
| ENOXABARA® 80 mg is a therapeutic anticoagulant used for active thromboembolic conditions such as DVT and pulmonary embolism. |
| Specifications: |
| 80 mg / 0.8 ml |
| Uses: |
| DVT treatment |
| Pulmonary embolism |
| High-risk anticoagulation |
FAQ
What is it used for?
| Treatment of thromboembolic conditions |
Where used?
| Hospitals and ICU |
Enoxabara Enoxaparin 40 mg Injection
Enoxabara Enoxaparin 40 mg Anti-Xa injection for anticoagulant support and thrombosis prevention in Libya.